Epithelial-mesenchymal transition: A new target in anticancer drug discovery

Giorgio Stassi, Fabrizio Marcucci, Ruggero De Maria

Risultato della ricerca: Articlepeer review

178 Citazioni (Scopus)

Abstract

The conversion of cells with an epithelial phenotype into cells with a mesenchymal phenotype, referred to as epithelial-mesenchymal transition, is a critical process for embryonic development that also occurs in adult life, particularly during tumour progression. Tumour cells undergoing epithelial-mesenchymal transition acquire the capacity to disarm the body's antitumour defences, resist apoptosis and anticancer drugs, disseminate throughout the organism, and act as a reservoir that replenishes and expands the tumour cell population. Epithelial-mesenchymal transition is therefore becoming a target of prime interest for anticancer therapy. Here, we discuss the screening and classification of compounds that affect epithelial-mesenchymal transition, highlight some compounds of particular interest, and address issues related to their clinical application.
Lingua originaleEnglish
pagine (da-a)311-325
Numero di pagine15
RivistaNature Reviews Drug Discovery
Volume15
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Fingerprint Entra nei temi di ricerca di 'Epithelial-mesenchymal transition: A new target in anticancer drug discovery'. Insieme formano una fingerprint unica.

Cita questo